SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950144-08-008239
Filing Date
2008-11-06
Accepted
2008-11-06 17:21:31
Documents
5
Period of Report
2008-09-30
Filing Date Changed
2008-11-06

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. - FORM 10-Q g16100e10vq.htm 10-Q 1236607
2 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g16100exv31w1.htm EX-31.1 9220
3 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g16100exv31w2.htm EX-31.2 9212
4 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g16100exv32w1.htm EX-32.1 3841
5 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g16100exv32w2.htm EX-32.2 3833
  Complete submission text file 0000950144-08-008239.txt   1264081
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 081168115
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1